O1‐09‐04: UPDATE ON THE SAFETY AND TOLERABILITY OF GANTENERUMAB IN THE ONGOING OPEN‐LABEL EXTENSION (OLE) OF THE MARGUERITE ROAD STUDY IN PATIENTS WITH MILD ALZHEIMER'S DISEASE (AD) AFTER APPROXIMATELY TWO YEARS OF STUDY DURATION

Saved in:
Bibliographic Details
Published inAlzheimer's & dementia Vol. 14; no. 7S_Part_4; p. P241
Main Authors Abi-Saab, Danielle, Andjelkovic, Mirjana, Pross, Nathalie, Delmar, Paul, Voyle, Nicola, Klein, Gregory, Esau, Nelli, Ristic, Smiljana, Martenyi, Ferenc, Fontoura, Paulo, Doody, Rachelle
Format Journal Article
LanguageEnglish
Published 01.07.2018
Online AccessGet full text

Cover

Author Delmar, Paul
Ristic, Smiljana
Martenyi, Ferenc
Pross, Nathalie
Klein, Gregory
Fontoura, Paulo
Voyle, Nicola
Doody, Rachelle
Abi-Saab, Danielle
Andjelkovic, Mirjana
Esau, Nelli
Author_xml – sequence: 1
  givenname: Danielle
  surname: Abi-Saab
  fullname: Abi-Saab, Danielle
  email: danielle.abi-saab@roche.com
  organization: F. Hoffmann-La Roche Ltd
– sequence: 2
  givenname: Mirjana
  surname: Andjelkovic
  fullname: Andjelkovic, Mirjana
  organization: F. Hoffmann-La Roche Ltd
– sequence: 3
  givenname: Nathalie
  surname: Pross
  fullname: Pross, Nathalie
  organization: F. Hoffmann-La Roche Ltd
– sequence: 4
  givenname: Paul
  surname: Delmar
  fullname: Delmar, Paul
  organization: F. Hoffmann-La Roche Ltd
– sequence: 5
  givenname: Nicola
  surname: Voyle
  fullname: Voyle, Nicola
  organization: Roche Products Ltd
– sequence: 6
  givenname: Gregory
  surname: Klein
  fullname: Klein, Gregory
  organization: F. Hoffmann-La Roche Ltd
– sequence: 7
  givenname: Nelli
  surname: Esau
  fullname: Esau, Nelli
  organization: F. Hoffmann-La Roche Ltd
– sequence: 8
  givenname: Smiljana
  surname: Ristic
  fullname: Ristic, Smiljana
  organization: F. Hoffmann-La Roche Ltd
– sequence: 9
  givenname: Ferenc
  surname: Martenyi
  fullname: Martenyi, Ferenc
  organization: F. Hoffmann-La Roche Ltd
– sequence: 10
  givenname: Paulo
  surname: Fontoura
  fullname: Fontoura, Paulo
  organization: F. Hoffmann-La Roche Ltd
– sequence: 11
  givenname: Rachelle
  surname: Doody
  fullname: Doody, Rachelle
  organization: Genentech, Inc
BookMark eNqNkb1u2zAUhYUiBZqfPkGXuzUZrJKyfrvRFi0zoEiBopC4iyAzFBDDTQJrCJKpj9Bn7NqXKBkXnbtcEhfnfPeS5yw4eXh8sEHwCaMQI5x-2YW7Yf8aRgjnIUrDaJ7jd8EpTpJolkRZcfLvnqIPwdk07RCKUY6T0-C3xL9-_ESFL_FX6JqSaApSgF5TaMmK6g0QUYKWnCqyYJy5hlxBRYSmgqquJgtgR7kUlWSiAtlQ4XicLCgHeut0LXPES4e48l6vrYmqOqqYG6YkKaHVXbnxoIZoRoVu4YbpNdSMl0D4tzVlNVWfWyhZS0lL4ZKUV0BWmiogTaPkLavd4nwD-kbChhLV-klHatkpB5XiIng_DvvJfvx7ngede99yPeOyYkvCZwYnMZ5tTRTZGCV5kZskHoyN4mywJjMpzvJxHNB4lyVmO6RmHO1dYbeZ3doUR4Ud5iYrovl5MD9yzeFxmg527J8O99-Hw0uPUe_z6ne9z6v3efUo7X1ezrU8up7v9_blfyy9-5jra1d8E6VvlD-pQZN5
CitedBy_id crossref_primary_10_1186_s13195_022_01110_8
crossref_primary_10_1186_s13195_020_00663_w
crossref_primary_10_1002_cpt_2535
crossref_primary_10_1080_14728214_2020_1808621
crossref_primary_10_1186_s13195_019_0559_z
ContentType Journal Article
Copyright 2018 The Alzheimer's Association
Copyright_xml – notice: 2018 The Alzheimer's Association
DBID AAYXX
CITATION
DOI 10.1016/j.jalz.2018.06.2381
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
EISSN 1552-5279
EndPage P241
ExternalDocumentID 10_1016_j_jalz_2018_06_2381
ALZJJALZ2018062381
Genre abstract
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1OC
1~.
1~5
24P
33P
4.4
457
4G.
53G
5VS
7-5
71M
7RV
7X7
8FI
8FJ
8P~
AACTN
AAEDT
AAHHS
AAIKJ
AAKOC
AALRI
AANLZ
AAOAW
AAXLA
AAXUO
ABBQC
ABCQJ
ABCUV
ABIVO
ABJNI
ABMAC
ABMZM
ABUWG
ACCFJ
ACCZN
ACGFS
ACGOF
ACPOU
ACXQS
ADBBV
ADBTR
ADEZE
ADHUB
ADKYN
ADMUD
ADPDF
ADVLN
ADZMN
ADZOD
AEEZP
AEIGN
AEKER
AENEX
AEQDE
AEUYR
AEVXI
AFKRA
AFTJW
AGHFR
AGUBO
AGWIK
AGYEJ
AITUG
AIURR
AIWBW
AJBDE
AJOXV
AJRQY
AKRWK
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMFUW
AMRAJ
AMYDB
ANZVX
AZQEC
BENPR
BFHJK
BLXMC
C45
CCPQU
DCZOG
EBS
EJD
EMOBN
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FNPLU
FYUFA
G-Q
GBLVA
HMCUK
HVGLF
HX~
HZ~
IHE
J1W
K9-
LATKE
LEEKS
M0R
M41
MO0
MOBAO
N9A
NAPCQ
O-L
O9-
OAUVE
OVD
OVEED
OZT
P-8
P-9
P2P
PC.
PGMZT
PIMPY
PSYQQ
Q38
QTD
RIG
ROL
RPM
RPZ
SDF
SDG
SEL
SES
SSZ
SUPJJ
T5K
TEORI
UKHRP
~G-
AAYXX
ACRPL
ADNMO
CITATION
ID FETCH-LOGICAL-c1541-bc22e405898c54ace247aec7c6178ffa0fd75cba6cffed9eb7ebe6129ea3c7923
ISSN 1552-5260
IngestDate Fri Dec 06 04:21:16 EST 2024
Sat Aug 24 01:08:43 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 7S_Part_4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1541-bc22e405898c54ace247aec7c6178ffa0fd75cba6cffed9eb7ebe6129ea3c7923
PageCount 1
ParticipantIDs crossref_primary_10_1016_j_jalz_2018_06_2381
wiley_primary_10_1016_j_jalz_2018_06_2381_ALZJJALZ2018062381
PublicationCentury 2000
PublicationDate July 2018
2018-07-00
PublicationDateYYYYMMDD 2018-07-01
PublicationDate_xml – month: 07
  year: 2018
  text: July 2018
PublicationDecade 2010
PublicationTitle Alzheimer's & dementia
PublicationYear 2018
SSID ssj0040815
Score 2.240338
SourceID crossref
wiley
SourceType Aggregation Database
Publisher
StartPage P241
Title O1‐09‐04: UPDATE ON THE SAFETY AND TOLERABILITY OF GANTENERUMAB IN THE ONGOING OPEN‐LABEL EXTENSION (OLE) OF THE MARGUERITE ROAD STUDY IN PATIENTS WITH MILD ALZHEIMER'S DISEASE (AD) AFTER APPROXIMATELY TWO YEARS OF STUDY DURATION
URI https://onlinelibrary.wiley.com/doi/abs/10.1016%2Fj.jalz.2018.06.2381
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtNAELb6c-GCQIAoBbQHJFoZV05sxwnissWbxpVjW7FDk14s_6xFQpSi0l564hF4Rq68BDO7tuOqHApcNs5qdlbOfLM7s5mdUZQ3edYDo2JQaIbV72lmt5tqaWnkmpVmRWYaZWEP8ILz2O-NpubpzJptbZetqKXrq-wov_njvZJ_kSr0gVzxluxfSLZhCh3wDPKFFiQM7b1kHHSaWAV9sHk00c2fhg6NmRr4IqgnokMWz0UuqTjw2IQeu54LHcFQPaF-jPFr0zE9Vl1JHvgnAR5jBSHzG74ePWaeymZAjSuwSFTqMTxWqCKHxnRyMgXHEKadBNQR1uYcWYY0dpkfR-qZG4_Uses5KvXOR8wdYxyGHamOGzEaMWRJHeRIh2BmqzQMJ8HMHcOLeHM1PgvUOaMTUW1d8namrTO2Opfu6uYzX4iiMPY3gexCHIEumg2IZgstStNsc8V-tQH-uljy1ZcLWEDlrYLLZbpuRoZ1kXkf_3JYLZphDl9VoepNqGV1lNLpN2G3zepvoWcuCxwc8XafrHjTbBlmSzXsKAkBAonZ2gfCrkznVdkU9dc7-5U8OlkeLdPVDcYZimSyaEVttuc6JKEht-4xQGY09s5PT6FBMr2HRNvKLiaMNHeU3eATY05ts5hgGFois3D1A9T5uUQk5J25btlwbZ9OGGXxI-Vh5U0RKlXjsbLF10-UX0Hn5_cf-gAb8z2RikACnwBGiVQEAopA2opAgiFpKwJxJXmlCAQVAfgJFSCNCpADYHGIY5F2A3-C8CcCosiohj9B-BOEP2ng_zYiFfjJAXUOiQA-uQV8AsAnAvg4k-RaA_-pMoX3-TjSqpomWg7OSkfL8m6Xm1jLs59bZprzrmmnPLdzvKpblqkOq6OVZ2kvL0teDHhmwyoLXsiAp0aOuT6fKTvrizV_rhDD7nMzBT4GfOr9FPPsG_2y0HO94GW3s6e8q6WUfJWpa5I6pnOZoFATFGqi9xIU6p7yQUjyPrTJXWi9-L_h-8qDjUa-VHauLq_5KzD3r7LXFVZ_A2TM1Lc
link.rule.ids 314,780,784,27924,27925
linkProvider Ovid
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=O1%E2%80%9009%E2%80%9004%3A+UPDATE+ON+THE+SAFETY+AND+TOLERABILITY+OF+GANTENERUMAB+IN+THE+ONGOING+OPEN%E2%80%90LABEL+EXTENSION+%28OLE%29+OF+THE+MARGUERITE+ROAD+STUDY+IN+PATIENTS+WITH+MILD+ALZHEIMER%27S+DISEASE+%28AD%29+AFTER+APPROXIMATELY+TWO+YEARS+OF+STUDY+DURATION&rft.jtitle=Alzheimer%27s+%26+dementia&rft.au=Abi-Saab%2C+Danielle&rft.au=Andjelkovic%2C+Mirjana&rft.au=Pross%2C+Nathalie&rft.au=Delmar%2C+Paul&rft.date=2018-07-01&rft.issn=1552-5260&rft.eissn=1552-5279&rft.volume=14&rft.issue=7S_Part_4&rft.spage=P241&rft.epage=P241&rft_id=info:doi/10.1016%2Fj.jalz.2018.06.2381&rft.externalDBID=10.1016%252Fj.jalz.2018.06.2381&rft.externalDocID=ALZJJALZ2018062381
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-5260&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-5260&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-5260&client=summon